The Efficacy Of Therapy With Abt-414, An Egfr-Targeting Adc, Is Potentially Altered By Heterozygous Deletion Of The Endocytic Trafficking Regulator RbsnGaelle Muller-Greven,Bianca-Maria Marin,Cathleen Carlin,Edward Reilly,Jeongwu Lee,Marcus Bredel,Jann Sarkaria,Candece GladsonNeuro-oncology(2018)引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要